Abbott issues US device correction for some glucose monitors over faulty readings risk
AbbottAbbott(US:ABT) Reuters·2025-11-24 16:08

Core Viewpoint - Abbott Laboratories has initiated a recall in the United States for specific FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring sensors due to internal testing revealing certain issues [1] Group 1 - The recall affects certain models of the FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring sensors [1] - Internal testing conducted by the company indicated that some sensors may not perform as expected [1] - The company is taking corrective actions to address the identified issues with the sensors [1]